Advertisement.

ACHFF Projected Dividend Yield

Arch Biopartners Inc ( OTCBB : ACHFF )

Arch Biopartners is a portfolio-based biotechnology company. Co. is focused on the clinical development of its drug candidate, Metablok TM or "LSALT peptide", has the potential to treat or prevent dipeptidase-1 mediated organ inflammation in the lungs, liver or kidneys including in the case of sepsis and COVID-19. Co. also has three additional technology platforms in its portfolio under development: AB569, a drug candidate for treating antibiotic resistant bacterial infection; Borg: Peptide-Solid Surface Interface to inhibit biofilm formation and reduce corrosion; and MetaMx TM - proprietary synthetic molecules that target brain tumour initiating cells and invasive glioma cells.

20 YEAR PERFORMANCE RESULTS

ACHFF Dividend History Detail
ACHFF Dividend News
ACHFF Competitors News

# of Shares: 0

Closing Price: 1.32

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000